Just like that, 4DX hits $2/sh out gate on Monday – up +250% WoW
4DX Medical (ASX:4DX), a company now offering next-gen lung scanning technology to the U.S. markets (and still hot after a recent FDA approval for that jurisdiction) soared above the $2/sh mark out the gate on Monday trades, spurred by a fresh announcement that sent its shares another +30% higher...
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online